Diabetes prevalence based on health insurance claims: Large differences between companies

Diabetic Medicine

Volumn 28, Issue 8, 2011, Pages 919-923

  Hoffmann, F ^a   Icks, A ^b  

^a UNIVERSITY OF BREMEN   (Germany)

^b HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Cross sectional studies; Diabetes mellitus; Health insurance companies; Prevalence

Indexed keywords

INSULIN;

ADULT; AGED; ANTHROPOMETRY; ARTICLE; ASTHMA; BODY MASS; COMORBIDITY; COMPARATIVE STUDY; CONTROLLED STUDY; DIABETES MELLITUS; EDUCATIONAL STATUS; FEMALE; GERMANY; HEALTH BELIEF; HEALTH INSURANCE; HEALTH SURVEY; HEART FAILURE; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; NEURODERMATITIS; PREVALENCE; SELF EVALUATION; SMOKING; STROKE;

ADOLESCENT; ADULT; AGED; DIABETES MELLITUS; FEMALE; GERMANY; HUMANS; INSURANCE CLAIM REPORTING; INSURANCE, HEALTH; LOGISTIC MODELS; MALE; MIDDLE AGED; PREVALENCE; YOUNG ADULT;

EID: 79960258635     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/j.1464-5491.2011.03305.x     Document Type: Article

References (25)

1. Hoffmann F. Review on use of German health insurance medication claims data for epidemiological research. Pharmacoepidemiol Drug Saf 2009; 18: 349-356.
2. Schneeweiss S, Avorn J. A review of uses of health care utilization databases for epidemiologic research on therapeutics. J Clin Epidemiol 2005; 58: 323-337.
3. Tricco AC, Pham B, Rawson NS. Manitoba and Saskatchewan administrative health care utilization databases are used differently to answer epidemiologic research questions. J Clin Epidemiol 2008; 61: 192-197.
4. Nichols GA, Glauber HS, Brown JB. Type 2 diabetes: incremental medical care costs during the 8years preceding diagnosis. Diabetes Care 2000; 23: 1654-1659.
5. Nichols GA, Brown JB. Higher medical care costs accompany impaired fasting glucose. Diabetes Care 2005; 28: 2223-2229.
6. Selby JV, Ray GT, Zhang D, Colby CJ. Excess costs of medical care for patients with diabetes in a managed care population. Diabetes Care 1997; 20: 1396-1402.
7. Köster I, von Ferber L, Ihle P, Schubert I, Hauner H. The cost burden of diabetes mellitus: the evidence from Germany-the CoDiM Study. Diabetologia 2006; 9: 1498-1504.
8. Sicree R, Shaw J, Zimmer P. The Global Burden. Diabetes and Impaired Glucose Tolerance. In: International Diabetes Federation, ed. IDF Diabetes Atlas, 4th edn. Brussels: International Diabetes Federation, 2010.
9. Zhang P, Zhang X, Brown JB, Vistisen D, Sicree RA, Shaw J et al. Economic Impact of Diabetes. In: International Diabetes Federation, ed. IDF Diabetes Atlas 4th edn. Brussels, International Diabetes Federation, 2010.
10. Geyer S, Peter R, Nielsen I. Health inequalities in different age groups: the case of type 2 diabetes: a study with health insurance and medication data. Soz Praventivmed 2004; 49: 328-335.
11. Hauner H, Köster I, Schubert I. Trends in der Prävalenz und ambulanten Versorgung von Menschen mit Diabetes mellitus. Eine Analyse der Versichertenstichprobe AOK Hessen/KV Hessen im Zeitraum von 1998 bis 2004 (Prevalence of Diabetes mellitus and Quality of Care in Hesse, Germany, 1998-2004). Dtsch Ärztebl 2007; 104: A2799-2805.
12. Icks A, Haastert B, Trautner C, Giani G, Glaeske G, Hoffmann F. Incidence of lower-limb amputations in the diabetic compared to the non-diabetic population. Findings from nationwide insurance data, Germany, 2005-2007. Exp Clin Endocrinol Diabetes 2009; 117: 500-504.
13. Stock SA, Redaelli M, Wendland G, Civello D, Lauterbach KW. Diabetes-prevalence and cost of illness in Germany: a study evaluating data from the statutory health insurance in Germany. Diabet Med 2006; 23: 299-305.
14. von Ferber L, Köster I, Hauner H. Medical costs of diabetic complications. Total costs and excess costs by age and type of treatment. Results of the German CoDiM Study. Exp Clin Endocrinol Diabetes 2007; 115: 97-104.
15. Heidemann C, Kroll L, Icks A, Lampert T, Scheidt-Nave C. Prevalence of known diabetes in German adults aged 25-69years: results from national health surveys over 15years. Diabet Med 2009; 26: 655-658.
16. Meisinger C, Heier M, Doering A, Thorand B, Loewel H; KORA Group. Prevalence of known diabetes and antidiabetic therapy between 1984/1985 and 1999/2001 in southern Germany. Diabetes Care 2004; 27: 2985-2987.
17. Eliasson M, Lindahl B, Lundberg V, Stegmayr B. No increase in the prevalence of known diabetes between 1986 and 1999 in subjects 25-64years of age in northern Sweden. Diabet Med 2002; 19: 874-880.
18. BMG. Gesetzliche Krankenversicherung: Mitglieder, mitversicherte Angehörige, Beitragssätze und Krankenstand. Monatswerte Januar-Dezember 2008 (Ergebnisse der GKV-Statistik KM1), 2009 (Statutory Health Insurance: Members, Co-Insured Dependents, Contribution Rates, January-December 2008). 2009. Available at Last accessed 15 April 2010. Archived by WebCite® at Last accessed 30 March 2011.
19. Lisac M, Reimers L, Henke KD, Schlette S. Access and choice-competition under the roof of solidarity in German health care: an analysis of health policy reforms since 2004. Health Econ Policy Law 2010; 5: 31-52.
20. Güther B. Gesundheitsmonitor-Stichprobe und Erhebungsmethode sowie Qualitätsaspekte der Ergebnisse (Healthcare Monitor- Sampling, Methodology and Quality Issues). In: Böcken J, Braun B, Amhof R, Schnee M, eds. Gesundheitsmonitor 2006 (Healthcare Monitor 2006). Gütersloh: Verlag Bertelsmann-Stiftung, 2006: 309-322.
21. Rückert IM, Böcken J, Mielck A. Are German patients burdened by the practice charge for physician visits ('Praxisgebuehr')? A cross-sectional analysis of socio-economic and health-related factors. BMC Health Serv Res 2008; 8: 232.
22. Bramesfeld A, Grobe TG, Schwartz FW. Who is diagnosed as suffering from depression in the German statutory health care system? An analysis of health insurance data. Eur J Epidemiol 2007; 22: 397-403.
23. von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP. STROBE initiative. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. PLoS Med 2007; 4: e296.
24. Pigeot I, Ahrens W. Establishment of a pharmacoepidemiological database in Germany: methodological potential, scientific value and practical limitations. Pharmacoepidemiol Drug Saf 2008; 17: 215-223.
25. Schnee M: Sozioökonomische Strukturen und Morbidität in den gesetzlichen Krankenkassen (Socio-Economic Structure And Morbidity in the Statutory Health Insurance Funds). In: Böcken J, Braun B, Amhof R, eds. Gesundheitsmonitor 2008 (Healthcare Monitor 2008). Gütersloh: Verlag Bertelsmann Stiftung, 2008: 88-104.